Introducing Provectus Therapeutics
Mr. Marco SUEN
Co-Founder & Chief Executive Officer (CEO)
Mr. Suen is responsible for Business Development, Company’s Operation and Research & Development (Biomedical).
He is experienced in designing, manufacturing, and applying Organ-on-a-chip technology to conduct single-cell analysis for drug screening. He managed multiple innovative projects related to AI in Bioimage Analysis, Genetic Analysis for Breast Cancer Prediction and Neural Network Construction for skin cancer diagnosis.
Mr. Tony TO
Co-Founder & Chief Technology Officer (CTO)
Tony has rich experiences in software development, database construction and AI construction on real-time computer vision. He aims to improve our living standards by applying AI technologies to biomedical fields. Associating his professional background in Computer Science, he combines science and engineering to create feasible technologies for better healthcare.